In a total of 845 HCC patients, the elevated expression of UBE2S was significantly associated with higher tumor grade, larger tumor volume, vascular invasion, higher serum AFP level, advanced TNM stage, recurrence, and poorer outcomes (Pan et al., 2018). The gene discussed is UBE2S; the disease is neoplasm.